Treatment of Wet, Macerated Interdigital Infections

Initial Assessment and Pathogen Recognition

Culture specimens should be obtained from deep tissue after cleansing and debridement before starting antibiotics, avoiding superficial swabs, as recommended by the Infectious Diseases Society of America 1, 2

For severe infections, the American College of Clinical Pharmacy recommends ciprofloxacin 500-750 mg PO twice daily or 400 mg IV every 8 hours, which is highly effective with reliable activity against Pseudomonas and Proteus 3
The Infectious Diseases Society of America suggests piperacillin-tazobactam as the preferred broad-spectrum parenteral agent for severe infections requiring hospitalization 4

Recent hospitalization or frequent antibiotic use are key risk factors that mandate antipseudomonal coverage, according to the Society for Healthcare Epidemiology of America 4
Warm climate or frequent water exposure of the affected area are also risk factors that require antipseudomonal coverage, as stated by the European Society of Clinical Microbiology and Infectious Diseases 5, 6

For mild infections, the Infectious Diseases Society of America recommends 1-2 weeks of therapy 1, 2
For moderate to severe infections, the American College of Clinical Pharmacy suggests 2-3 weeks of therapy, with a standard duration of 14 days for confirmed Pseudomonas or Proteus 1, 4

Once culture results are available, the Infectious Diseases Society of America recommends narrowing the spectrum of antibiotics when possible to prevent resistance development if the patient is improving on empiric therapy 3, 5
The European Society of Clinical Microbiology and Infectious Diseases suggests broadening coverage to include all isolated organisms if the infection is worsening despite empiric therapy 6, 2

The Society for Healthcare Epidemiology of America advises against empirically covering Pseudomonas without documented risk factors, as this is a common error that drives resistance 4, 6
The American College of Clinical Pharmacy recommends avoiding reliance solely on antibiotics without addressing moisture control and wound care, as this is insufficient for resolution 1

High-dose ciprofloxacin (750 mg every 12 hours) achieves superior serum and tissue concentrations compared to lower doses, which is critical for eradicating Pseudomonas in patients with interdigital infections, according to the European Respiratory Journal 7
Levofloxacin 750 mg once daily can be considered as an alternative fluoroquinolone with antipseudomonal activity, though clinical experience is more limited than with ciprofloxacin, as reported in the European Respiratory Journal 7

If worsening despite empiric therapy, broaden coverage to ensure all isolated organisms are targeted based on culture results, as recommended by Clinical Infectious Diseases 8
If improving on empiric ciprofloxacin, continue the regimen even if culture sensitivities suggest other options, as clinical response supersedes in vitro data, according to Clinical Infectious Diseases 8

Pseudomonas is often a colonizer rather than true pathogen in wounds—however, in the context of clinical infection signs (erythema, purulence, pain) between toes with positive cultures, treat as a pathogen, as noted in Clinical Infectious Diseases 8 and 9
Do not empirically cover Pseudomonas without documented risk factors in other clinical scenarios, but the wet interdigital environment IS a documented risk factor requiring coverage, as stated in Clinical Infectious Diseases 9